LifeStance Health Group (NASDAQ:LFST) Stock Price Target Raised at KeyCorp

Key Points

• KeyCorp raised LifeStance Health Group’s price target to $15 from $13 and maintained an “overweight” rating, implying 26.8% upside from the prior close.
• Analyst sentiment remains positive, with the stock carrying a “Moderate Buy” consensus rating and an average price target of $13.12; BTIG Research has the highest target at $18.
• LifeStance reported quarterly EPS of $0.06 versus the $0.03 consensus estimate, while revenue rose 26.1% year over year to $435.35 million. However, insiders sold roughly $146.4 million of shares over the past three months.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) had its target price lifted by research analysts at KeyCorp from $13.00 to $15.00 in a research note issued on Monday, Benzinga reports. The brokerage currently has an "overweight" rating on the stock. KeyCorp's price objective suggests a potential upside of 26.80% from the stock's previous close.

Several other equities research analysts have also commented on the stock. Barclays raised their price target on shares of LifeStance Health Group from $13.00 to $15.00 and gave the company an "overweight" rating in a research note on Thursday, September 10th. Wall Street Zen cut shares of LifeStance Health Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday, September 5th. Weiss Ratings upgraded LifeStance Health Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, August 11th. BTIG Research raised their price objective on shares of LifeStance Health Group from $16.00 to $18.00 and gave the stock a "buy" rating in a research note on Wednesday, August 19th. Finally, Zacks Research downgraded LifeStance Health Group from a "strong-buy" rating to a "hold" rating in a report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat, LifeStance Health Group currently has an average rating of "Moderate Buy" and an average target price of $13.12.

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST opened at $11.83 on Monday. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. The company has a fifty day simple moving average of $12.07 and a 200 day simple moving average of $9.58. The firm has a market cap of $4.52 billion, a PE ratio of 91.01 and a beta of 1.24. LifeStance Health Group has a 12-month low of $4.77 and a 12-month high of $13.56.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.03. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The firm had revenue of $435.35 million for the quarter, compared to analysts' expectations of $414.58 million. During the same period in the prior year, the company posted ($0.01) earnings per share. The firm's quarterly revenue was up 26.1% on a year-over-year basis. On average, equities research analysts anticipate that LifeStance Health Group will post 0.16 EPS for the current fiscal year.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, CTO Vukasin Paunovich sold 44,394 shares of the business's stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $10.85, for a total value of $481,674.90. Following the transaction, the chief technology officer directly owned 247,446 shares in the company, valued at $2,684,789.10. The trade was a 15.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.62, for a total value of $144,890,858.34. Following the sale, the insider owned 98,101,407 shares in the company, valued at $1,041,836,942.34. The trade was a 12.21% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 13,777,580 shares of company stock valued at $146,433,781. 3.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On LifeStance Health Group

Hedge funds and other institutional investors have recently made changes to their positions in the company. WINTON GROUP Ltd lifted its holdings in shares of LifeStance Health Group by 522.3% during the 2nd quarter. WINTON GROUP Ltd now owns 186,589 shares of the company's stock valued at $1,998,000 after purchasing an additional 156,607 shares in the last quarter. Engineers Gate Manager LP acquired a new stake in LifeStance Health Group in the 2nd quarter valued at $166,000. Integrated Wealth Concepts LLC acquired a new stake in shares of LifeStance Health Group in the second quarter valued at about $91,000. IFP Advisors Inc boosted its holdings in shares of LifeStance Health Group by 316.5% in the 2nd quarter. IFP Advisors Inc now owns 3,694 shares of the company's stock valued at $40,000 after buying an additional 2,807 shares during the last quarter. Finally, Squarepoint Ops LLC acquired a new stake in LifeStance Health Group in the second quarter valued at $1,283,000. 85.50% of the stock is owned by institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc is a U.S.-based healthcare company that provides outpatient mental health services through a network of clinicians. Its services are delivered through both in-person appointments and a virtual care platform, allowing patients to access care in a range of settings.

The company offers psychiatric evaluation and treatment, psychotherapy, medication management, psychological and neuropsychological testing, and related behavioral health services. LifeStance serves children, adolescents, and adults, addressing conditions such as anxiety, depression, attention-deficit/hyperactivity disorder, and other mental health and behavioral concerns.

LifeStance operates across multiple states in the United States and combines company-operated clinics with telehealth services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.